If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

  • This share is currently suspended. It was suspended at a price of 7.23
  • There is currently no data for TRX

EPT Disclosure

21 Jul 2005 11:10

UBS AG (EPT)21 July 2005 FORM 38.5 DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS (Rule 38.5 of The City Code on Takeovers and Mergers) Name of exempt principal trader UBS AG Company dealt in TOREX RETAIL PLCRelevant security dealt in ORDINARY SHARES 1P Name of offeree/offeror with whom connected TOREX RETAIL PLCNature of connection # FINANCIAL ADVISERDate of dealing 20 July 2005 85,000 Total number of securities bought 118.00 GBP Highest price paid (currency must be stated) 118.00 GBP Lowest price paid (currency must be stated) 86,857 Total number of securities sold 118.00 GBP Highest price paid (currency must be stated) 118.00 GBP Lowest price paid (currency must be stated) Date of disclosure 21 July 2005 Contact name ROBIN RAGNUTH 020 7567 8289 Telephone number # See the definition of "connected fund managers and principal traders" in theDefinitions Section of the Code. For details of the Code's dealing disclosure requirements, see Rules 8 and 38.5and their Notes which can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
28th Jun 20217:00 amRNSCompletion of phase 1 of new US facility expansion
23rd Jun 20216:08 pmRNSDirector/PDMR Shareholding
10th Jun 20214:17 pmRNSHolding(s) in Company
3rd Jun 20211:37 pmRNSResult of AGM
11th May 20217:00 amRNSDirector/PDMR Shareholding
10th May 202110:00 amRNSDirector/PDMR Shareholding
5th May 20217:00 amRNSGrant of share options
29th Apr 20214:11 pmRNSHolding(s) in Company
28th Apr 20217:00 amRNSFinal Results and Notice of AGM
20th Apr 20211:07 pmRNSHolding(s) in Company
20th Apr 202112:10 pmRNSHolding(s) in Company
19th Apr 20217:00 amRNSNotice of Results
13th Apr 20217:00 amRNSHolding(s) in Company
1st Apr 20214:40 pmRNSSecond Price Monitoring Extn
1st Apr 20214:36 pmRNSPrice Monitoring Extension
18th Mar 20217:00 amRNSInitial phase of US facility expansion complete
26th Feb 20217:00 amRNSDirectorate Change
19th Feb 20213:52 pmRNSHolding(s) in Company
11th Feb 20217:00 amRNSMove to Electronic Reporting
8th Feb 20217:00 amRNSTrading Update
5th Feb 20214:40 pmRNSSecond Price Monitoring Extn
5th Feb 20214:35 pmRNSPrice Monitoring Extension
21st Jan 20217:00 amRNSAppointment of Chief Financial Officer
6th Jan 20213:58 pmRNSPDMR Dealings
5th Jan 20217:00 amRNSConfirmation of Board appointments
4th Jan 202111:26 amRNSHoldings in Company
24th Dec 202012:56 pmRNSIssue of Equity & Total Voting Rights Replacement
24th Dec 202011:15 amRNSHoldings in Company
23rd Dec 20209:51 amRNSIssue of Equity and Total Voting Rights
4th Dec 20207:00 amRNSBoard Changes
3rd Dec 20204:54 pmRNSHoldings in Company
2nd Dec 20207:00 amRNSFirst delivery of OrthoPure® XT
27th Nov 20209:09 amRNSHoldings in Company
26th Nov 20204:02 pmRNSHoldings in Company
17th Nov 20207:00 amRNSAppointment of CEO
6th Nov 20207:00 amRNSHoldings in Company
29th Oct 20207:00 amRNSHoldings in Company
29th Oct 20207:00 amRNSChange of Registered Office
26th Oct 20204:50 pmRNSHoldings in Company
7th Oct 20201:50 pmEQSHardman & Co Research: Tissue Regenix (TRX): Funded through to profitability
28th Sep 202012:24 pmRNSHoldings in Company
16th Sep 20207:42 amRNSHoldings in Company
15th Sep 20204:40 pmRNSSecond Price Monitoring Extn
15th Sep 20204:35 pmRNSPrice Monitoring Extension
14th Sep 20205:33 pmRNSHoldings in Company
2nd Sep 20207:00 amRNSUnaudited Interim Results
27th Aug 20207:00 amRNSNotice of Interim Results & Investor Presentation
24th Aug 20207:00 amRNSUK distribution partner for OrthoPure® XT
18th Aug 202011:27 amRNSHoldings in Company
17th Aug 20207:00 amRNSRelocation of UK office and manufacturing facility

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.